Main > A1. CORP. INDEX. V-Vm > Vanda Pharmaceuticals/P C2



Vanda Pharmaceuticals/P C2's subsections
2012. 04.16. NK-1 R AntAgonist
2012. 06.18. BoD
2012. 08.09. Schizo. IL
2013. 01.31. MDD
2013. 03.14. Schizo. EU
2014. 01.31. Blind>Non-24 Hour Dis.
2024. 01.26. USA Patent
2024. 07.01. Federal Court Allows
Web-Site
Z - OK

Vanda Pharmaceuticals/P C2's products
This section has no products